These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 25991427)
21. Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines. Kawa S; Nikaido T; Aoki Y; Zhai Y; Kumagaya T; Furihata K; Fujii S; Kiyosawa K Int J Cancer; 1997 Sep; 72(5):906-11. PubMed ID: 9311612 [TBL] [Abstract][Full Text] [Related]
22. CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells. Chen NN; Li Y; Wu ML; Liu ZL; Fu YS; Kong QY; Chen XY; Li H; Liu J Exp Dermatol; 2012 Jan; 21(1):13-8. PubMed ID: 22082219 [TBL] [Abstract][Full Text] [Related]
23. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma. Jones E; Korzenko A; Kriegel D J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602 [TBL] [Abstract][Full Text] [Related]
24. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction. Dai XY; Zeng XX; Peng F; Han YY; Lin HJ; Xu YZ; Zhou T; Xie G; Deng Y; Mao YQ; Yu LT; Yang L; Zhao YL Cell Physiol Biochem; 2012; 29(1-2):281-90. PubMed ID: 22415097 [TBL] [Abstract][Full Text] [Related]
25. A new Prenylated Flavonoid induces G0/G1 arrest and apoptosis through p38/JNK MAPK pathways in Human Hepatocellular Carcinoma cells. Wang D; Sun Q; Wu J; Wang W; Yao G; Li T; Li X; Li L; Zhang Y; Cui W; Song S Sci Rep; 2017 Jul; 7(1):5736. PubMed ID: 28720813 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib. Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967 [TBL] [Abstract][Full Text] [Related]
27. The effects of 5-fluorouracil alone and in combination with 13-cis retinoic acid and vitamin D3 on human oral squamous cell carcinoma lines. Dalirsani Z; Farajnia S; Javadzadeh Y; Mehdipour M; Koozegari S J Contemp Dent Pract; 2012 May; 13(3):345-50. PubMed ID: 22918008 [TBL] [Abstract][Full Text] [Related]
28. A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis. Balasubramanian S; Chandraratna RA; Eckert RL Oncogene; 2005 Jun; 24(26):4257-70. PubMed ID: 15856029 [TBL] [Abstract][Full Text] [Related]
29. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990 [TBL] [Abstract][Full Text] [Related]
31. Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2. Farshchian M; Nissinen L; Grénman R; Kähäri VM Exp Dermatol; 2017 Jan; 26(1):89-92. PubMed ID: 27305645 [No Abstract] [Full Text] [Related]
32. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines. Crowe DL; Shuler CF Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460 [TBL] [Abstract][Full Text] [Related]
34. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo. Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428 [TBL] [Abstract][Full Text] [Related]
35. A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. Shalinsky DR; Bischoff ED; Lamph WW; Zhang L; Boehm MF; Davies PJ; Nadzan AM; Heyman RA Cancer Res; 1997 Jan; 57(1):162-8. PubMed ID: 8988059 [TBL] [Abstract][Full Text] [Related]
36. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969 [TBL] [Abstract][Full Text] [Related]
37. Cyclin proteolysis as a retinoid cancer prevention mechanism. Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432 [TBL] [Abstract][Full Text] [Related]
38. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells. Zou CP; Hong WK; Lotan R Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809 [TBL] [Abstract][Full Text] [Related]
40. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Ben-Dor A; Nahum A; Danilenko M; Giat Y; Stahl W; Martin HD; Emmerich T; Noy N; Levy J; Sharoni Y Arch Biochem Biophys; 2001 Jul; 391(2):295-302. PubMed ID: 11437362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]